Compare AMETEK's compounding story with other industrials by scanning our hand picked list of solid balance sheet and fundamentals (25 results) that aim to pair staying power with earnings momentum.
To own AMETEK, you need to believe the business can keep turning niche industrial technology into steady earnings growth, even as cycles in aerospace, defense, semiconductor and power markets ebb and flow. Recent record Q2 2026 results and higher earnings guidance support that long term compounding story rather than changing it.
In the near term, the key catalyst is ongoing execution in higher value segments such as AI related semiconductor, data center, defense and power infrastructure, along with integrating acquisitions such as Indicor. The biggest current risk is that a premium P/E multiple meets any slowdown in revenue or margin progress, which could weigh on the share price even if operations remain solid.
The most relevant update for that thesis is AMETEK’s timeline for its Q3 2026 earnings release and conference call on November 3, 2026. This is a clear, dated checkpoint where management will show whether momentum from record Q2 results and raised full year guidance is still flowing through orders, margins and cash generation.
That call should provide fresh detail on how sectors such as semiconductor, aerospace, medical, defense and automation are tracking, and how power and process instrumentation backlogs are converting into sales. It is also a chance to evaluate execution on acquisitions and any pressure in slower growth parts of the portfolio, both of which are important for sustaining AMETEK’s compounding story.
Analysts see AMETEK reaching US$11.3b in revenue and US$2.3b in earnings by 2029, based on assumed yearly top line expansion of 12.7% and an increase in profit from US$1.6b today to US$2.3b, which represents a rise of about US$0.7b in earnings from the current base.
Uncover why AMETEK's fair value indicates a 12% potential upside to its current price before that discount narrows.
Three fair value estimates from the Simply Wall St Community span roughly US$183 to about US$278 per share for AMETEK, a wide gap for the same stock. Those retail perspectives already differ sharply before factoring in recent record results, premium P/E risks and earnings guidance, so you are seeing genuinely divergent viewpoints worth exploring.
Explore 2 other AMETEK fair value estimates, including one that suggests as much as 26% downside from the current price.
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
Once you understand where AMETEK fits in your portfolio, it makes sense to line it up against other opportunities that share similar strengths or offer a different risk and income profile.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com